The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs -- A practical view / Christopher John Fowler en European Neuropsychopharmacology, Año 2015 - Vol. 25 - No.6 (Junio)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2015 - Vol. 25 - No.6 (Junio) . - pp. 749-762 Título : The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs -- A practical view Tipo de documento: texto impreso Autores: Christopher John Fowler, Autor Fecha de publicación: 2021 Artículo en la página: pp. 749-762 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Endocannabinoide, Amida hidrolasa de ácido graso, Lipasa de monoacilglicerol, Ansiedad, Depresión, Desarrollo - fármacos Resumen: The endocannabinoid system, comprising cannabinoid CB1 and CB2 receptors, their endogenous ligands anandamide and 2-arachidonoylglyerol, and their synthetic and metabolic enzymes, are involved in many biological processes in the body, ranging from appetite to bone turnover. Link: ./index.php?lvl=notice_display&id=26769 [artículo] The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs -- A practical view [texto impreso] / Christopher John Fowler, Autor . - 2021 . - pp. 749-762. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No.6 (Junio) . - pp. 749-762 Palabras clave: Endocannabinoide, Amida hidrolasa de ácido graso, Lipasa de monoacilglicerol, Ansiedad, Depresión, Desarrollo - fármacos Resumen: The endocannabinoid system, comprising cannabinoid CB1 and CB2 receptors, their endogenous ligands anandamide and 2-arachidonoylglyerol, and their synthetic and metabolic enzymes, are involved in many biological processes in the body, ranging from appetite to bone turnover. Link: ./index.php?lvl=notice_display&id=26769

---

1 (1 - 1 / 1)